Jay S. Duker's Net Worth
$644 Thousand
Who is Jay S. Duker?
Jay S. Duker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EyePoint Pharmaceuticals, Inc., and Eleven Biotherapeutics, Inc..
SEC CIK
Jay S. Duker's CIK is 0001630864
Past Insider Trading and Trends
2022 was Jay S. Duker's most active year for acquiring shares with 7 total transactions. Jay S. Duker's most active month to acquire stocks was the month of May. 2024 was Jay S. Duker's most active year for disposing of shares, totalling 10 transactions. Jay S. Duker's most active month to dispose stocks was the month of January. 2019 saw Jay S. Duker paying a total of $44,850.00 for 124,167 shares, this is the most they've acquired in one year. In 2024 Jay S. Duker cashed out on 90,046 shares for a total of $304,954.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $7.97
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.26% | 8.61K |
$8.69 | -$70,032.71 | 38.03K |
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
| 51.92K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
| 51.92K |
Feb 20
| |||
Form 4
| +19.39% | 8.43K |
$28.80 | -$101,750.40 | 51.92K |
Feb 9
| |||
Form 4
| +48.82% | 14.27K |
$20.40 | -$133,171.20 | 43.49K |
Jan 5 - Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +36.53% | 7.82K |
$4.17 | -$17,297.16 | 29.22K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +101.47% | 10.78K |
$5.42 | -$24,276.18 | 21.4K |
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +87.79% | 4.97K |
—
|
—
| 10.62K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
| +17.78% | 6.67K |
—
|
—
| 44.17K |
Jun 21
| |||
Form 4
| +114.29% | 20K |
$1.77 | $35,400.00 | 37.5K |
Apr 12
| |||
Form 4
| +40.00% | 5K |
$1.89 | $9,450.00 | 17.5K |
Apr 1
| |||
Form 4
|
∞
| 12.5K |
—
|
—
| 12.5K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eleven Biotherapeutics, Inc. (CARM) Snapshot price: $0.9803
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||